XNAS
ONCO
Market cap2mUSD
Jul 15, Last price
4.53USD
1D
14.18%
1Q
7,353.70%
IPO
-91.52%
Name
Blue Water Biotech Inc
Chart & Performance
P/E
—
P/S
40.44
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
58k
Net income
-37m
L+181.48%
CFO
-14m
L+56.12%
Profile
Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 58 | ||||
Cost of revenue | 17,906 | 13,481 | |||
Unusual Expense (Income) | |||||
NOPBT | (17,847) | (13,481) | |||
NOPBT Margin | |||||
Operating Taxes | (13) | (130) | |||
Tax Rate | |||||
NOPAT | (17,835) | (13,352) | |||
Net income | (37,410) 181.48% | (13,290) 288.91% | |||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | (59) | 34,301 | |||
BB yield | 1.74% | -254.11% | |||
| Debt | |||||
Debt current | 9,767 | ||||
Long-term debt | 342 | ||||
Deferred revenue | |||||
Other long-term liabilities | 1,420 | 1,499 | |||
Net debt | 5,554 | (25,753) | |||
| Cash flow | |||||
Cash from operating activities | (13,581) | (8,699) | |||
CAPEX | (55) | (9) | |||
Cash from investing activities | (8,649) | (9) | |||
Cash from financing activities | 1,035 | 32,532 | |||
FCF | (16,505) | (13,354) | |||
| Balance | |||||
Cash | 4,554 | 25,753 | |||
Long term investments | |||||
Excess cash | 4,551 | 25,753 | |||
Stockholders' equity | 16,838 | (19,376) | |||
Invested Capital | 71,166 | 41,587 | |||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | 17,111 | 12,271 | |||
Price | 0.20 -82.00% | 1.10 | |||
Market cap | 3,388 -74.90% | 13,499 | |||
EV | 80,185 | (12,254) | |||
EBITDA | (17,803) | (13,474) | |||
EV/EBITDA | 0.91 | ||||
Interest | 672 | 61 | |||
Interest/NOPBT | |||||